Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial

Nature Medicine published a placebo-controlled randomized clinical trial examining the hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity. The supplied information includes only the study title, with no results or conclusions provided.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.